Alliance Pharma is dedicated to bringing comprehensive solutions to our collaborative partnerships. We understand the importance of efficiency and our team of scientists strive to provide the highest analytical services for your project.
Our recent purchase of multiple Agilent 6545XT AdvanceBio QTOFs – which is specifically designed with biopharmaceutical characterization in mind - provides high resolution and sensitivity for qualitative and quantitative analyses of biomolecules ranging from peptides to intact monoclonal antibodies. The iterative peptide mapping workflow allows us to dig deep into samples with a wide range of analyte concentrations (i.e. host cell proteins and sequence variants). The Agilent 6545XT AdvanceBio QTOF maximizes our uptime by performing thousands of protein injections without degradation of performance with mass accuracies within 10 ppm for glycosylated intact proteins.
At Alliance Pharma we believe keeping up with the latest technology helps us to provide the best services for our clients. The 1290 Infinity II LC system when coupled with the 6545XT, represents the next generation LC for ultrahigh-performance liquid chromatography with superior reliability, offering efficient and reproducible separations of biomolecules for detection by MS or integrated UV and FLD modules.
By using instruments that complement our scientist’s knowledge and experience we meet analytical objectives, increase productivity, and are cost-effective. Contact us to see how our recent instrument purchase will help keep your project on track. Call or email Ryan at 919-801-3146 or email@example.com for more information.